(task) Fwd: Reminder: Ebola Vaccines and Antivirals: What Lies Ahead?

GRS Africa RSs and RI

4 cover

Ebola Phase III

Begin forwarded message:

> From: "J. Stephen Morrison, SmartGlobalHealth.org" <smorrison@smartglobalhealth.org>
> Subject: Reminder: Ebola Vaccines and Antivirals: What Lies Ahead?
> Date: December 10, 2014 at 3:37:06 PM EST
> To: Michael McDonald <michael.d.mcdonald@mac.com>
> Reply-To: info@smartglobalhealth.org
>
>
> Ebola Vaccines and Antivirals: What Lies Ahead?
>
> 3:00PM - 5:00PM (EST)
> Tuesday, December 16, 2014
>
> 2nd Floor Conference Room
> Center for Strategic and International Studies
> 1616 Rhode Island Avenue, NW
> Washington, D.C. 20036
>
> There are rapidly accelerating efforts underway by industry, governments, NGOS, international organizations, and foundations to bring forward Ebola vaccines and antivirals. There have been promising early returns, amidst considerable unknowns and acute pressures to find safe, effective, and affordable new technological tools. Ambitious field trials are set to begin in the new year in West Africa. Hear what lies ahead from those on the front lines:
>
> Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Disease (NIAID)
> Dr. Moncef Slaoui, Member of the GSK Board of Directors and the Corporate Executive Team
> Dr. Johan Van Hoof, Global Therapeutic Area Head, Infectious Diseases and Vaccines, Janssen Research & Development, LLC
> Dr. Rohit Malpani, Director of Policy and Analysis, Medecins Sans Frontieres Access Campaign
> Dr. Julie Gerberding, President, Merck Vaccines
>
> Dr. J. Stephen Morrison, Senior Vice President and Director of the CSIS Global Health Policy Center will moderate the panel.
>
> Please RSVP here.
>
>
> © 2014 Center for Strategic and International Studies | Privacy Policy | Unsubscribe
> Banner image © UNICEF Iran, Amir Mohsen Rezapour. Used with permission.
>
>